Bin Zhang

Bin Zhang currently serves as Senior Vice President of Oncology Clinical Development at Crinetics Pharmaceuticals, with prior leadership roles at BioAtla, Inc., Pyxis Oncology, and Ipsen, encompassing responsibilities in clinical development and asset management. Experience includes significant contributions at Bristol-Myers Squibb as Director of Global Clinical Research and leadership positions at Abt Bio-Pharma Solutions, Boston Health Economics, and the New England Healthcare Institute. Bin Zhang's medical training includes internships and fellowships at Peking Union Medical College Hospital, with advanced academic credentials from Harvard T.H. Chan School of Public Health and China Medical University.